{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:33:10Z","timestamp":1792251190046,"version":"4.4.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.pcl.2013.09.002","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T23:35:32Z","timestamp":1384299332000},"page":"1419-1441","source":"Crossref","is-referenced-by-count":33,"title":["Inherited Abnormalities of Coagulation"],"prefix":"10.1016","volume":"60","author":[{"given":"Riten","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Carcao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/pbc.22988","article-title":"Platelet disorders in children: a diagnostic approach","volume":"56","author":"Israels","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2013.09.002_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/pbc.24345","article-title":"What we have learned from inherited platelet disorders","volume":"60","author":"Israels","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pcl.2013.09.002_bib3","series-title":"Primary and secondary hemostasis, regulators of coagulation, and fibrinolysis: understanding the basics. SickKids handbook of pediatric thrombosis and hemostasis","author":"Revel-Vilk","year":"2013"},{"issue":"5","key":"10.1016\/j.pcl.2013.09.002_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/07853890.2011.576698","article-title":"Inherited disorders of blood coagulation","volume":"44","author":"Lippi","year":"2012","journal-title":"An Med"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0029-1214144","article-title":"Milestones and perspectives in coagulation and hemostasis","volume":"35","author":"Lippi","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pcl.2013.09.002_bib6","series-title":"Mechanisms of Hemostasis and Thrombosis. Disorders of Haemostasis and Thrombosis","author":"Goodnight","year":"2001"},{"issue":"7","key":"10.1016\/j.pcl.2013.09.002_bib7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4065\/82.7.864","article-title":"How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults","volume":"82","author":"Kamal","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib8","first-page":"165","article-title":"Biochemistry and physiology of blood coagulation","volume":"82","author":"Mann","year":"1999","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib9","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1111\/j.1365-2516.2011.02588.x","article-title":"A\u00a0study of variations in the reported haemophilia B prevalence around the world","volume":"18","author":"Stonebraker","year":"2012","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2516.2009.02127.x","article-title":"A\u00a0study of variations in the reported haemophilia A prevalence around the world","volume":"16","author":"Stonebraker","year":"2010","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.pcl.2013.09.002_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I","article-title":"Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators","volume":"59","author":"Soucie","year":"1998","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0037-1615621","article-title":"Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis","volume":"85","author":"White","year":"2001","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/mp.55.2.127","article-title":"Haemophilia A and haemophilia B: molecular insights","volume":"55","author":"Bowen","year":"2002","journal-title":"Mol Pathol"},{"issue":"5992","key":"10.1016\/j.pcl.2013.09.002_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/312326a0","article-title":"Characterization of the human factor VIII gene","volume":"312","author":"Gitschier","year":"1984","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.pcl.2013.09.002_bib15","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1021\/bi00335a049","article-title":"Nucleotide sequence of the gene for human factor IX (antihemophilic factor B)","volume":"24","author":"Yoshitake","year":"1985","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.pcl.2013.09.002_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0032-1326786","article-title":"The diagnosis and management of congenital hemophilia","volume":"38","author":"Carcao","year":"2012","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrg1617","article-title":"Haemophilia A: from mutation analysis to new therapies","volume":"6","author":"Graw","year":"2005","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.pcl.2013.09.002_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1365-2516.1998.440350.x","article-title":"The molecular basis of haemophilia B","volume":"4","author":"Lillicrap","year":"1998","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib19","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood.V86.6.2206.bloodjournal8662206","article-title":"Factor VIII gene inversions in severe hemophilia A: results of an international consortium study","volume":"86","author":"Antonarakis","year":"1995","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pcl.2013.09.002_bib20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/hmg\/3.7.1035","article-title":"Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells","volume":"3","author":"Rossiter","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.pcl.2013.09.002_bib21","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.V84.9.2992.2992","article-title":"Transcriptional control of the factor IX gene: analysis of five cis-acting elements and the deleterious effects of naturally occurring hemophilia B Leyden mutations","volume":"84","author":"Picketts","year":"1994","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.pcl.2013.09.002_bib22","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1182\/blood-2012-11-469403","article-title":"Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A","volume":"121","author":"Carcao","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pcl.2013.09.002_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/hae.12133","article-title":"Is haemophilia B less severe than haemophilia A?","volume":"19","author":"Mannucci","year":"2013","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.pcl.2013.09.002_bib24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-0031-1297164","article-title":"Pediatric hemophilia: a review","volume":"37","author":"Kulkarni","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1365-2516.2009.02074.x","article-title":"Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project","volume":"15","author":"Kulkarni","year":"2009","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2141.2011.08967.x","article-title":"Neonatal bleeding in haemophilia: a European cohort study","volume":"156","author":"Richards","year":"2012","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.pcl.2013.09.002_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00043426-199907000-00009","article-title":"Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature","volume":"21","author":"Kulkarni","year":"1999","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2516.2009.02142.x","article-title":"The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery","volume":"16","author":"James","year":"2010","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2516.2009.02144.x","article-title":"The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery","volume":"16","author":"Ljung","year":"2010","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2141.2010.08545.x","article-title":"Guideline on the management of haemophilia in the fetus and neonate","volume":"154","author":"Chalmers","year":"2011","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2141.2010.08469.x","article-title":"Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States","volume":"152","author":"Witmer","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.pcl.2013.09.002_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2516.2005.01124.x","article-title":"Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed","volume":"11","author":"van Dijk","year":"2005","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0029-1222609","article-title":"Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of inherited thrombophilia","volume":"35","author":"Franchini","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib34","first-page":"305","article-title":"Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature","volume":"92","author":"van Dijk","year":"2004","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.pcl.2013.09.002_bib35","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2010.03962.x","article-title":"Blood-induced joint disease: the pathophysiology of hemophilic arthropathy","volume":"8","author":"Valentino","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.pcl.2013.09.002_bib36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2516.2011.02720.x","article-title":"Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world","volume":"18","author":"Sorensen","year":"2012","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/pbc.22678","article-title":"Pelvic pseudotumor and pseudoaneurysm in a pediatric patient with moderate hemophilia B: successful management with arterial embolization and surgical excision","volume":"56","author":"Kumar","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2013.09.002_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2012.02796.x","article-title":"Management of bleeding disorders in children","volume":"18","author":"Berntorp","year":"2012","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2516.2011.02671.x","article-title":"Recommendations for assessment, monitoring and follow-up of patients with haemophilia","volume":"18","author":"de Moerloose","year":"2012","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2013.09.002_bib40","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/pbc.24339","article-title":"Importance of pharmacokinetics in the management of hemophilia","volume":"60","author":"Barnes","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1538-7836.2009.03703.x","article-title":"Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens","volume":"8","author":"Collins","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.pcl.2013.09.002_bib42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2516.2012.02810.x","article-title":"Continuous infusion in haemophilia: current practice in Europe","volume":"18","author":"Batorova","year":"2012","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.pcl.2013.09.002_bib43","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.moh.0000239701.32674.e0","article-title":"Continuous infusion of coagulation factors: current opinion","volume":"13","author":"Batorova","year":"2006","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib44","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.pcl.2013.09.002_bib45","doi-asserted-by":"crossref","unstructured":"Robertson JD, Curtin JA, Blanchette VS. Managing Hemophilia in Children and Adolescents. Sick Kids Handbook of pediatric thrombosis and hemostasis. 1st edition. Basel (Switzerland) Karger; 2013.","DOI":"10.1159\/000346924"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0038-1657659","article-title":"Desmopressin: twenty years after","volume":"78","author":"Mannucci","year":"1997","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2516.2011.02572.x","article-title":"DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII: C level and with haemophilic genotype","volume":"18","author":"Seary","year":"2012","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1651-2227.1976.tb16525.x","article-title":"Haemophilia prophylaxis in Sweden","volume":"65","author":"Nilsson","year":"1976","journal-title":"Acta Paediatr Scand"},{"issue":"Suppl 77","key":"10.1016\/j.pcl.2013.09.002_bib49","first-page":"73","article-title":"Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B","author":"Ahlberg","year":"1965","journal-title":"Acta Orthop Scand Suppl"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00546.x","article-title":"Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B","volume":"232","author":"Nilsson","year":"1992","journal-title":"J\u00a0Intern Med"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.blre.2010.10.001","article-title":"Venous access in the management of hemophilia","volume":"25","author":"Valentino","year":"2011","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib53","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1538-7836.2006.01953.x","article-title":"Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study","volume":"4","author":"Feldman","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pcl.2013.09.002_bib54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/asheducation-2011.1.397","article-title":"Biological rationale for new drugs in the bleeding disorders pipeline","volume":"2011","author":"Fogarty","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"25","key":"10.1016\/j.pcl.2013.09.002_bib55","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.pcl.2013.09.002_bib56","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2516.2009.01999.x","article-title":"Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs","volume":"15","author":"Santagostino","year":"2009","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.pcl.2013.09.002_bib57","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis","volume":"119","author":"Gouw","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.pcl.2013.09.002_bib58","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1538-7836.2009.03636.x","article-title":"Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A","volume":"7","author":"Pavlova","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"10.1016\/j.pcl.2013.09.002_bib59","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2006-11-056317","article-title":"Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study","volume":"109","author":"Gouw","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1208024","article-title":"Factor VIII products and inhibitor development in severe hemophilia A","volume":"368","author":"Gouw","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib61","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1538-7836.2010.03823.x","article-title":"Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review","volume":"8","author":"Iorio","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib62","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2006-04-017988","article-title":"A\u00a0randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study","volume":"109","author":"Astermark","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib63","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"The principal results of the International Immune Tolerance Study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"issue":"Suppl 6","key":"10.1016\/j.pcl.2013.09.002_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2006.01359.x","article-title":"Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference","volume":"12","author":"Berntorp","year":"2006","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2141.2006.06087.x","article-title":"The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation","volume":"133","author":"Hay","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib66","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib67","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib69","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bjh.12249","article-title":"The molecular characterization of von Willebrand disease: good in parts","volume":"161","author":"James","year":"2013","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pcl.2008.01.008","article-title":"Von Willebrand disease","volume":"55","author":"Robertson","year":"2008","journal-title":"Pediatr Clin North Am"},{"issue":"33","key":"10.1016\/j.pcl.2013.09.002_bib71","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.pcl.2013.09.002_bib72","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI112129","article-title":"Substructure of human von Willebrand factor","volume":"76","author":"Fowler","year":"1985","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.pcl.2013.09.002_bib73","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.pcl.2013.09.002_bib74","first-page":"630","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105.","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.pcl.2013.09.002_bib77","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2141.1998.00656.x","article-title":"The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children","volume":"101","author":"Carcao","year":"1998","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib79","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-0037-1614035","article-title":"von Willebrand disease in a pediatric-based population\u2013comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor\/collagen-binding assay","volume":"84","author":"Dean","year":"2000","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.pcl.2013.09.002_bib80","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1649589","article-title":"Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"70","author":"Conlan","year":"1993","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.pcl.2013.09.002_bib81","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1537-2995.2006.00975.x","article-title":"ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?","volume":"46","author":"Jenkins","year":"2006","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.pcl.2013.09.002_bib82","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib83","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/pbc.23120","article-title":"Therapeutic consequences for misdiagnosis of type 2N von Willebrand disease","volume":"57","author":"Gupta","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib84","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2516.2010.02356.x","article-title":"Intranasal oestrogen cream for the prevention of epistaxis in patients with bleeding disorders","volume":"17","author":"Ross","year":"2011","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2013.09.002_bib85","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1002\/pbc.24335","article-title":"The use of DDAVP in children with bleeding disorders","volume":"60","author":"Ben-Ami","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.pcl.2013.09.002_bib86","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2516.2012.02916.x","article-title":"Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)","volume":"19","author":"Abshire","year":"2013","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib87","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood-2009-01-153296","article-title":"How I treat von Willebrand disease","volume":"114","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2013.09.002_bib88","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1002\/pbc.24336","article-title":"The rare inherited coagulation disorders","volume":"60","author":"Bolton-Maggs","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.pcl.2013.09.002_bib89","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2004-02-0595","article-title":"Recessively inherited coagulation disorders","volume":"104","author":"Mannucci","year":"2004","journal-title":"Blood"},{"issue":"Suppl 4","key":"10.1016\/j.pcl.2013.09.002_bib90","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2516.2012.02841.x","article-title":"Rare bleeding disorders","volume":"18","author":"Peyvandi","year":"2012","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib91","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2516.2008.01667.x","article-title":"Factor XI deficiency","volume":"14","author":"Gomez","year":"2008","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib92","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1365-2516.2008.01844.x","article-title":"Factor VII deficiency: defining the clinical picture and optimizing therapeutic options","volume":"14","author":"Lapecorella","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2013.09.002_bib93","first-page":"s45","article-title":"National and international registries of rare bleeding disorders","volume":"6","author":"Peyvandi","year":"2008","journal-title":"Blood Transfus"},{"issue":"9","key":"10.1016\/j.pcl.2013.09.002_bib94","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1538-7836.2012.04844.x","article-title":"Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"10.1016\/j.pcl.2013.09.002_bib95","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1538-7836.2011.04315.x","article-title":"Diagnosis and classification of factor XIII deficiencies","volume":"9","author":"Kohler","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib96","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1365-2516.2008.01831.x","article-title":"Rare inherited disorders of fibrinogen","volume":"14","author":"Acharya","year":"2008","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib97","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1365-2516.2008.01857.x","article-title":"Factor XIII deficiency","volume":"14","author":"Hsieh","year":"2008","journal-title":"Haemophilia"},{"issue":"22","key":"10.1016\/j.pcl.2013.09.002_bib98","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2011-10-386045","article-title":"Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency","volume":"119","author":"Inbal","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib99","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-2516.2008.01856.x","article-title":"Diagnosis and treatment of inherited factor X deficiency","volume":"14","author":"Brown","year":"2008","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib100","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1365-2516.2008.01785.x","article-title":"Factor V deficiency: a concise review","volume":"14","author":"Huang","year":"2008","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2013.09.002_bib101","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2516.2008.01832.x","article-title":"Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment","volume":"14","author":"Meeks","year":"2008","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.pcl.2013.09.002_bib102","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2516.2004.00944.x","article-title":"The rare coagulation disorders\u2013review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"10","author":"Bolton-Maggs","year":"2004","journal-title":"Haemophilia"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395513001259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395513001259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T11:33:21Z","timestamp":1716118401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395513001259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0031395513001259"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2013.09.002","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}